-
Featured
New Targeted Glioma Therapy Could Suppress Tumor Growth
Mass General has developed a genotype-targeted therapy for glioma, designed to be given at the tumor site during surgery, and an accompanying rapid diagnostic.
-
Featured
Surviving Gliomas Through Antibodies and Vaccination
Immunotherapy for glioma is under active investigation, but tumor-associated immunosuppression is a major obstacle. A Mass General team studied an investigational monoclonal antibody in mice with glioma, alone and in combination with tumor cell vaccination.
-
Featured
How Liquid Biopsy Could Improve Brain Tumor Treatment and Diagnoses
Mass General doctors are developing a liquid biopsy for brain tumors to reduce the need for invasive tissue biopsies.
-
How Microfluidics Could Improve Neurosurgery
A team at Mass General are studying how the field of microfluidics could improve neurosurgical patient care, particularly in patients with brain tumors.
Brain Tumor contributors
-
Bob S. Carter, MD, PhD
Chief, Neurosurgery Service
Recent Article
Specialization Improves Neurosurgery Outcomes Regardless of Case Volume
-
Brian V. Nahed, MD, MSc
Neurosurgical Oncology / Brain Tumor Surgeon / Mass General Brain Tumor Center, Neurosurgical Spinal Disorders, Associate Professor, Harvard Medical School
Associate Director Mass General Neurosurgery ProgramRecent Article
How Microfluidics Could Improve Neurosurgery
-
Daniel P. Cahill, MD, PhD
Neurosurgeon
Recent Article
New Targeted Glioma Therapy Could Suppress Tumor Growth
-
William T. Curry, MD
Co-Director, Mass General Neuroscience , Director of Neurosurgical Oncology
Recent Article
Surviving Gliomas Through Antibodies and Vaccination
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.Resource Links
